Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €72.82 EUR
Change Today +0.067 / 0.09%
Volume 0.0
As of 1:02 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

varian medical systems inc (VNM) Snapshot

Open
€72.47
Previous Close
€72.76
Day High
€73.69
Day Low
€69.66
52 Week High
03/16/15 - €89.87
52 Week Low
10/15/14 - €59.56
Market Cap
7.2B
Average Volume 10 Days
29.6
EPS TTM
--
Shares Outstanding
98.7M
EX-Date
01/5/99
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VARIAN MEDICAL SYSTEMS INC (VNM)

varian medical systems inc (VNM) Related Businessweek News

View More BusinessWeek News

varian medical systems inc (VNM) Details

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions in the United States. The company operates in two segments, Oncology Systems and Imaging Components. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, and image processing software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices, and cancer care clinics. The Imaging Components segment provides X-ray imaging components to large imaging system original equipment manufacturers (OEMs) for use in radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, and industrial applications; and X-ray tubes and flat panel digital image detectors to small OEMs, independent service companies, and end-users for filmless X-ray imaging. This segment also offers Linatron X-ray accelerators, imaging processing software, and image detection products for security and inspection purposes, such as cargo screening at ports and borders, and nondestructive examination in various applications. Varian Medical Systems, Inc. also provides products and systems for delivering proton therapy; and develops various technologies in the areas of digital X-ray imaging, volumetric and functional imaging, and improved X-ray sources. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.

6,800 Employees
Last Reported Date: 11/25/14
Founded in 1948

varian medical systems inc (VNM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $934.6K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $587.0K
Executive Vice President and President of Onc...
Total Annual Compensation: $567.0K
Senior Vice President and President of Imagin...
Total Annual Compensation: $513.8K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $429.9K
Compensation as of Fiscal Year 2014.

varian medical systems inc (VNM) Key Developments

Varian Medical Systems, Inc. Receives Tender to Equip Network of Hospitals in Northwest Spain

Varian Medical Systems, Inc. has been awarded an eight-year tender to supply advanced radiotherapy equipment and software to a network of hospitals in Galicia, in the northwest of Spain. Varian booked the order, worth an estimated €21 million, in its fiscal third quarter. Under the terms of the agreement Varian will supply 10 linear accelerators, including three advanced TrueBeam systems, to five hospitals in the SERGAS network of hospitals in the Galicia region. Varian will also be installing its full suite of treatment planning software and oncology information management systems across the network. Under this investment project, the five public hospitals, Centro Oncologico de Galicia, Hospital Lucus Augusti de Lugo, Complejo Hospitalario Universitario de Santiago, Complejo Hospitalario Universitario de Vigo and Complejo Hospitalario Universitario de Ourense will also be connected within Varian's ARIA network, enabling greater integration and knowledge-sharing between the five departments. This will be the first time the five centers have been connected in this way. In total, Varian will be supplying three TrueBeam systems, six Clinac iX machines, and a Unique system to the five hospitals. Two of the hospitals currently use Varian equipment, while two more are equipped with systems from other suppliers. The fifth center is being upgraded to deliver radiotherapy for the first time.

Varian Medical Systems, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2015; Provides Earnings Guidance for the Year 2015

Varian Medical Systems, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended June 30, 2015. For the quarter, the company reported revenues of $784.0 million against $747.7 million a year ago. Operating earnings were $144.2 million against $142.5 million a year ago. Earnings before taxes was $145.9 million against $143.8 million a year ago. Net earnings attributable to company was $113.5 million against $107.1 million a year ago. Net earnings per diluted share attributable to Varian was $1.13 against $1.02 a year ago. Third quarter net earnings per diluted share rose 11% versus the year-ago period when the company recorded a $0.06 per diluted share charge related to the impairment of a portion of the company's investment in Augmenix. Cash flow from operations was $184 million, significantly higher than net income, due primarily to working capital improvement. For the nine months, revenues of $2,281.3 million against $2,237.7 million a year ago. Operating earnings were $419.7 million against $412 million a year ago. Earnings before taxes was $423.4 million against $414.3 million a year ago. Net earnings attributable to company was $312.8 million against $297.8 million a year ago. Net earnings per diluted share attributable to Varian was $3.10 against $2.81 a year ago. Cash flow from operations was $316 million. The company expects that revenues for the full fiscal year will increase by about 2% in dollars and by about 6% in constant currency. It ended the second quarter with earnings guidance for fiscal 2015 in the range of $4.02 to $4.14 per diluted share. As of the end of the third quarter, with the approximately $0.22 per diluted share for the booking of the Maryland proton therapy system partially offset by ongoing challenges in Imaging Components business, the company now believe that its earnings for fiscal 2015 could be in the range of $4.20 to $4.25 per diluted share. Non-GAAP earnings for fiscal year 2015 should be higher than the GAAP range by approximately $0.16 per diluted share, comprised of restructuring charges in the first half of fiscal year 2015, acquisition related costs, and amortization of acquisition related intangibles. Given the ongoing geographic mix shift, the profits to outside North America and the German tax loss carry forward, it now believe the tax rate for the full fiscal year will be about 27%.

Varian Medical Systems to Equip New York Proton Consortium with ProBeam System

Varian Medical Systems announced that it has entered into an agreement with New York Proton Management LLC to operate The New York Proton Center, the first proton facility in New York State. Varian will provide the center, which will have four treatment rooms and a research room, with its ProBeam system, as well as 10 years of service for approximately $115 million. The center, which will be located in Manhattan, is expected to open for treatment in the first half of 2018. Varian expects to book the equipment portion of the order in the fourth quarter of this fiscal year with the remainder of the order to be booked in accordance with the company's policies over the term of the agreement. Under an agreement with MM Proton I, LLC, the project developer, Varian's international subsidiary in Switzerland will provide $91.5 million in project financing, including a six-and-half-year $73 million senior first lien loan at 9% interest and a six-and-half-year $18.5 million subordinate loan at up to 13.5% interest. Other lenders for the $242.7 million in total project loans include JPMorgan Chase Bank, N.A. and an affiliate of The Goldman Sachs Group, Inc. The project facility is managed by Murphy & McManus, a Boston-based developer of healthcare and life science facilities and Norton Travis of NLT Advisors served as project coordinator on behalf of the consortium. Varian's ProBeam system with Dynamic Peak Scanning is uniquely capable of high-speed intensity modulated proton therapy (IMPT) which is the most precise form of proton therapy available. The Varian installation will include its ARIA® information management system and Eclipse treatment planning software. Varian's ProBeam technology is being used to treat patients at the Scripps Proton Therapy Center in San Diego, the Rinecker Proton Therapy Center in Munich, and at the Paul Scherrer Institute in Switzerland.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNM:GR €72.82 EUR +0.067

VNM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $52.61 USD -0.65
MEDNAX Inc $81.00 USD -0.57
Mettler-Toledo International Inc $297.79 USD -2.42
ResMed Inc $52.11 USD -0.36
Cooper Cos Inc/The $163.01 USD -1.73
View Industry Companies
 

Industry Analysis

VNM

Industry Average

Valuation VNM Industry Range
Price/Earnings 20.0x
Price/Sales 2.7x
Price/Book 4.7x
Price/Cash Flow 19.4x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VARIAN MEDICAL SYSTEMS INC, please visit www.varian.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.